Abbott Laboratories
ABT131.420USD
-2.310-1.73%
Đóng cửa 09/15, 16:00（ET）Báo giá bị trễ 15 phút
228.73BVốn hóa
16.36P/E TTM
Thêm thông tin về Abbott Laboratories Công ty
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.
Thông tin công ty
Mã chứng khoánABT
Tên công tyAbbott Laboratories
Ngày IPOMar 01, 1937
Giám đốc điều hànhMr. Robert B. Ford
Số lượng nhân viên114000
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhMar 01
Địa chỉ100 Abbott Park Road
Thành phốABBOTT PARK
Sàn giao dịch chứng khoánNYSE Consolidated
Quốc giaUnited States of America
Mã bưu điện60064-3500
Điện thoại12246676100
Trang webhttps://www.abbott.com
Mã chứng khoánABT
Ngày IPOMar 01, 1937
Giám đốc điều hànhMr. Robert B. Ford
Lãnh đạo công ty
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-0.40%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
50.97K
-0.75%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
+4.17%
Ms. Nancy Mckinstry
Ms. Nancy Mckinstry
Lead Independent Director
Lead Independent Director
38.72K
+4.41%
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
34.06K
-2.76%
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-0.40%
Phân tích doanh thu
Tiền tệ: USDThời gian cập nhật: CN, 6 Th07
Tiền tệ: USDThời gian cập nhật: CN, 6 Th07
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Theo Doanh nghiệpUSD
Tên
Doanh thu
Tỷ trọng
Diabetes Care
1.83B
17.64%
Core Laboratory
1.18B
11.36%
Adult Nutritionals
1.10B
10.67%
Pediatric Nutritionals
1.04B
10.05%
Key Emerging Markets
965.00M
9.32%
Khác
4.24B
40.96%
Theo Khu vựcUSD
Tên
Doanh thu
Tỷ trọng
All other Countries
6.19B
59.76%
United States
4.17B
40.24%
Theo Doanh nghiệp
Theo Khu vực
Theo Doanh nghiệpUSD
Tên
Doanh thu
Tỷ trọng
Diabetes Care
1.83B
17.64%
Core Laboratory
1.18B
11.36%
Adult Nutritionals
1.10B
10.67%
Pediatric Nutritionals
1.04B
10.05%
Key Emerging Markets
965.00M
9.32%
Khác
4.24B
40.96%
Thống kê Cổ phần
Thời gian cập nhật: T6, 15 Th08
Thời gian cập nhật: T6, 15 Th08
Cổ đông
Loại Cổ đông
Cổ đông
Cổ đông
Tỷ trọng
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
5.09%
State Street Global Advisors (US)
4.50%
Capital International Investors
3.46%
Capital Research Global Investors
2.40%
Khác
74.67%
Cổ đông
Cổ đông
Tỷ trọng
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
5.09%
State Street Global Advisors (US)
4.50%
Capital International Investors
3.46%
Capital Research Global Investors
2.40%
Khác
74.67%
Loại Cổ đông
Cổ đông
Tỷ trọng
Investment Advisor
46.42%
Investment Advisor/Hedge Fund
23.17%
Research Firm
3.60%
Bank and Trust
2.24%
Pension Fund
2.21%
Sovereign Wealth Fund
1.37%
Insurance Company
1.06%
Individual Investor
0.48%
Hedge Fund
0.44%
Khác
18.99%
Cổ phần của tổ chức
Thời gian cập nhật: T3, 1 Th07
Thời gian cập nhật: T3, 1 Th07
Chu kỳ Báo cáo
Số lượng tổ chức
Cổ phiếu nắm giữ
Tỷ trọng
Thay đổi
2025Q2
4616
1.41B
81.28%
+6.94M
2025Q1
4644
1.42B
81.42%
+12.91M
2024Q4
4535
1.39B
80.22%
+15.89M
2024Q3
4391
1.36B
78.29%
-11.85M
2024Q2
4400
1.36B
78.24%
-7.03M
2024Q1
4402
1.35B
77.67%
-9.71M
2023Q4
4429
1.35B
77.56%
-11.05M
2023Q3
4298
1.34B
77.39%
-25.33M
2023Q2
4297
1.35B
77.60%
-13.55M
2023Q1
4281
1.35B
77.46%
-8.61M
Xem thêm
Hoạt động của Cổ đông
Tên
Cổ phiếu nắm giữ
Tỷ trọng
Thay đổi
Thay đổi %
Ngày
The Vanguard Group, Inc.
169.07M
9.72%
+1.18M
+0.70%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
87.82M
5.05%
+752.19K
+0.86%
Mar 31, 2025
State Street Global Advisors (US)
77.66M
4.46%
+497.07K
+0.64%
Mar 31, 2025
Capital International Investors
66.82M
3.84%
-1.15M
-1.69%
Mar 31, 2025
Capital Research Global Investors
50.73M
2.92%
-3.36M
-6.22%
Mar 31, 2025
Geode Capital Management, L.L.C.
36.90M
2.12%
+1.23M
+3.46%
Mar 31, 2025
JP Morgan Asset Management
28.80M
1.66%
+3.67M
+14.58%
Mar 31, 2025
Wellington Management Company, LLP
29.76M
1.71%
+3.37M
+12.77%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
20.98M
1.21%
+626.72K
+3.08%
Dec 31, 2024
Wells Fargo Advisors
15.42M
0.89%
+165.54K
+1.09%
Mar 31, 2025
Xem thêm
ETF liên quan
Thời gian cập nhật: T3, 2 Th09
Thời gian cập nhật: T3, 2 Th09
Tên
Tỷ trọng
iShares U.S. Medical Devices ETF
16.79%
Goldman Sachs Future Health Care Equity ETF
6.3%
GMO US Quality ETF
5.19%
Invesco Pharmaceuticals ETF
4.64%
Polen Capital Global Growth ETF
4.64%
iShares U.S. Healthcare ETF
4.45%
Proshares Ultra Health Care
4.45%
Health Care Select Sector SPDR Fund
4.38%
AdvisorShares Focused Equity ETF
4.37%
Tema Heart & Health ETF
4.31%
Xem thêm
iShares U.S. Medical Devices ETF
Tỷ trọng16.79%
Goldman Sachs Future Health Care Equity ETF
Tỷ trọng6.3%
GMO US Quality ETF
Tỷ trọng5.19%
Invesco Pharmaceuticals ETF
Tỷ trọng4.64%
Polen Capital Global Growth ETF
Tỷ trọng4.64%
iShares U.S. Healthcare ETF
Tỷ trọng4.45%
Proshares Ultra Health Care
Tỷ trọng4.45%
Health Care Select Sector SPDR Fund
Tỷ trọng4.38%
AdvisorShares Focused Equity ETF
Tỷ trọng4.37%
Tema Heart & Health ETF
Tỷ trọng4.31%
Cổ tức
Tổng cộng
16.46B
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.
Ngày
Cổ tức
Ngày ghi sổ
Ngày thanh toán
Ngày không hưởng cổ tức
Dec 13, 2024
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option
Jan 15, 2025
Feb 14, 2025
Jan 15, 2025
Sep 19, 2024
ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024
Oct 15, 2024
Nov 15, 2024
Oct 15, 2024
Jun 15, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option
Jul 15, 2024
Aug 15, 2024
Jul 15, 2024
Feb 16, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024
Apr 15, 2024
May 15, 2024
Apr 12, 2024
Dec 15, 2023
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option
Jan 12, 2024
Feb 15, 2024
Jan 11, 2024
Sep 21, 2023
ABT.NB Final Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option
Oct 13, 2023
Nov 15, 2023
Oct 12, 2023
Jun 09, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 15, 2023 going ex on Jul 13, 2023 with reinvestment option
Jul 14, 2023
Aug 15, 2023
Jul 13, 2023
Feb 17, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on May 15, 2023 going ex on Apr 13, 2023 with reinvestment option
Apr 14, 2023
May 15, 2023
Apr 13, 2023
Dec 09, 2022
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 15, 2023 going ex on Jan 12, 2023 with reinvestment option
Jan 13, 2023
Feb 15, 2023
Jan 12, 2023
Sep 15, 2022
ABT.NB Final Cash Dividend of gross USD 0.47 paid on Nov 15, 2022 going ex on Oct 13, 2022 with reinvestment option
Oct 14, 2022
Nov 15, 2022
Oct 13, 2022
Xem thêm
Chia tách cổ phiếu
Ngày
Loại
Tỷ lệ
Không có dữ liệu
Ngày
Loại
Tỷ lệ
Không có dữ liệu
